国家医疗保障局：开展药品价格登记查询服务

Core Viewpoint - The National Healthcare Security Administration and the Beijing Municipal Government are enhancing cooperation to support the high-quality development of innovative drugs and promote the global pharmaceutical market [1] Group 1: Drug Price Registration System - A new drug price registration system is being established, allowing companies to voluntarily declare prices for innovative drugs and other pharmaceuticals [1] - The registration process follows the principle of "one location acceptance, nationwide sharing, global openness," and is operated by a state-owned enterprise in Beijing's Xicheng District [1] - The system will provide services for registration and inquiry, ensuring that drug market information is accessible to relevant institutions and the public [1] Group 2: Price Adjustment and Verification - Drug market participants can apply for price adjustments based on clinical value, supply-demand relationships, and competitive landscape [1] - The registration unit will verify the basic information of the company and drug, as well as the proof of the declared price before processing the registration [1] - A unique file will be created for each drug, ensuring proper documentation and storage of information [1] Group 3: Access to Price Information - Registered users can query drug prices through the "China Drug Price Registration System" after logging in [1] - Drug market participants can obtain a free Chinese version of the drug price information inquiry certificate after the platform completes the qualification verification [1] - Additional services such as obtaining price information in other languages, price comparisons, and notarization will be provided on a paid basis by the operating unit [2]